Expression of cell cycle inhibitors p21, p27, p14 and p16 in gliomas. Correlation with classic prognostic factors and patients' outcome
- 31 October 2007
- journal article
- Published by Wiley in Neuropathology
- Vol. 28 (1), 35-42
- https://doi.org/10.1111/j.1440-1789.2007.00844.x
Abstract
Gliomas are among the most aggressive and treatment-refractory of all human tumors. The aim of the present study is to evaluate the role of the expression of cell cycle molecules as prognostic indicators in gliomas. We immunohistochemically analyzed the expression of p21, p27, p14, p16, p53 and proliferation marker Ki67, in 67 low and high grade astrocytic tumors. High grade tumors exhibited higher labeling indices for Ki67 (P = 0.004), p53 (P = 0.039) and slightly higher index for p21 (P = 0.07) compared to low grade tumors. p14 and p16 were more frequently present in low grade tumors (P = 0.001 and P = 0.052, respectively). Worse survival was correlated with high grade tumors (P < 0.0001) and higher Ki67 index (P < 0.0001). Cox regression analysis revealed that only age, grade and marginally Ki67 index were independent prognostic factors. Cell cycle alterations are involved in the malignant progression of astrocytomas, but only age, tumor grade and proliferating index can predict the outcome of the patients with glioma.Keywords
This publication has 25 references indexed in Scilit:
- Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomasCancer, 2003
- Low expression of p27 indicates a poor prognosis in patients with high‐grade astrocytomasCancer, 2003
- Potential role of bcl-2 and ki-67 expression and apoptosis in colorectal carcinoma: a clinicopathologic study.Digestive Diseases and Sciences, 2003
- Evaluation of Molecular Markers in Low-Grade Diffuse AstrocytomasThe American Journal of Surgical Pathology, 2002
- The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2The EMBO Journal, 1998
- Analysis of p53 Mutation and Epidermal Growth Factor Receptor Amplification in Recurrent Gliomas with Malignant ProgressionJournal of Neuropathology and Experimental Neurology, 1996
- Cell Cycle and Cancer: Critical Events at the G1 Restriction PointCritical Reviews™ in Oncogenesis, 1996
- A tiger behind many doors: multiple genetic pathways to malignant gliomaTrends in Genetics, 1995
- Genetic alterations associated with the evolution and progression of astrocytic brain tumoursVirchows Archiv, 1995
- Genetic alterations in gliomasJournal of Neuro-Oncology, 1995